EA201891177A1 - PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIOUS AND INFLAMMATORY DISEASES OF LOCAL APPLICATION AND METHOD FOR ITS PREPARATION AND APPLICATION (OPTIONS) - Google Patents

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIOUS AND INFLAMMATORY DISEASES OF LOCAL APPLICATION AND METHOD FOR ITS PREPARATION AND APPLICATION (OPTIONS)

Info

Publication number
EA201891177A1
EA201891177A1 EA201891177A EA201891177A EA201891177A1 EA 201891177 A1 EA201891177 A1 EA 201891177A1 EA 201891177 A EA201891177 A EA 201891177A EA 201891177 A EA201891177 A EA 201891177A EA 201891177 A1 EA201891177 A1 EA 201891177A1
Authority
EA
Eurasian Patent Office
Prior art keywords
application
infectious
preparation
treatment
pharmaceutical composition
Prior art date
Application number
EA201891177A
Other languages
Russian (ru)
Other versions
EA039541B1 (en
Inventor
Кирилл Константинович Сыров
Владимир Викторович НЕСТЕРУК
Original Assignee
Общество с ограниченной ответственностью "ВАЛЕНТА ИНТЕЛЛЕКТ"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "ВАЛЕНТА ИНТЕЛЛЕКТ" filed Critical Общество с ограниченной ответственностью "ВАЛЕНТА ИНТЕЛЛЕКТ"
Priority claimed from PCT/RU2016/000815 external-priority patent/WO2017095266A1/en
Publication of EA201891177A1 publication Critical patent/EA201891177A1/en
Publication of EA039541B1 publication Critical patent/EA039541B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Abstract

Изобретение относится к области медицины и химико-фармацевтической промышленности. Предложена фармацевтическая композиция для лечения инфекционно-воспалительных заболеваний в виде раствора для местного применения, характеризующаяся тем, что она содержит в качестве активного начала комбинацию Грамицидина C дигидрохлорида и цетилпиридиния хлорида, в качестве вспомогательных веществ - этанол 96%, сукралозу, глицерол, лимонную кислоту моногидрат, натрия цитрат, полисорбат, метилпарабен, пропилпарабен, ароматизатор натуральный мятный, воду очищенную. Также предложен способ ее получения и применения.The invention relates to the field of medicine and pharmaceutical industry. The proposed pharmaceutical composition for the treatment of infectious and inflammatory diseases in the form of a solution for local use, characterized in that it contains as an active principle a combination of Gramicidin C dihydrochloride and cetylpyridinium chloride, as auxiliary substances - ethanol 96%, sucralose, glycerol, citric acid monohydrate , sodium citrate, polysorbate, methylparaben, propylparaben, natural mint flavor, purified water. A method for its preparation and use is also proposed.

EA201891177A 2016-06-29 2016-11-24 Pharmaceutical composition for topical application for treating infectious inflammatory diseases, method for production and use thereof EA039541B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2016125965A RU2627423C1 (en) 2016-06-29 2016-06-29 Pharmaceutical composition of local application for infectious inflammatory diseases treatment, and method for its production and application
PCT/RU2016/000815 WO2017095266A1 (en) 2015-12-01 2016-11-24 Pharmaceutical composition for topical application for treating infectious inflammatory diseases, and method for producing and using same (variants)

Publications (2)

Publication Number Publication Date
EA201891177A1 true EA201891177A1 (en) 2018-10-31
EA039541B1 EA039541B1 (en) 2022-02-08

Family

ID=59632633

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201891177A EA039541B1 (en) 2016-06-29 2016-11-24 Pharmaceutical composition for topical application for treating infectious inflammatory diseases, method for production and use thereof

Country Status (2)

Country Link
EA (1) EA039541B1 (en)
RU (1) RU2627423C1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2213558C1 (en) * 2002-09-30 2003-10-10 Нестерук Владимир Викторович Antibacterial agent
US20060024335A1 (en) * 2004-07-29 2006-02-02 Roger Stier E Oral compositions which mask the bitter taste of a bitter-tasting agent
DE102009008094A1 (en) * 2009-02-09 2010-08-19 Barnikol-Keuten, Doris, Dr. In situ adhesive gel-forming preparations, in particular for topical application to moisturized skin / mucosa
TWI632921B (en) * 2011-10-19 2018-08-21 大塚製藥股份有限公司 Solution for oral administration

Also Published As

Publication number Publication date
EA039541B1 (en) 2022-02-08
RU2627423C1 (en) 2017-08-08

Similar Documents

Publication Publication Date Title
EA201592250A1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of diseases
EA201592256A1 (en) DERIVATIVES OF IMIDAZOPIRROLIDINONE AND THEIR APPLICATION IN THE TREATMENT OF DISEASES
MX368504B (en) Amide derivatives and pharmaceutically acceptable salts thereof, preparation method therefor and medicinal application thereof.
EA201691151A1 (en) CONNECTIONS FOR THE TREATMENT OF PATIENTS WITH ROS1-MUTANT CANCER CELLS
EA201890767A1 (en) C4-MODIFIED OLEANOLIC ACID DERIVATIVES FOR INHIBITION OF IL-17 AND OTHER APPLICATIONS
EA201591751A1 (en) TRIPEPTIDE EPOKEKETONE PROTEASE INHIBITORS
MX2020010300A (en) Mono-(acid) salts of 6-aminoisoquinolines and uses thereof.
EA201592255A1 (en) DERIVATIVES OF PYRAZOLOPIRROLIDIN-4-IT AS A BET INHIBITOR AND THEIR APPLICATION IN THE TREATMENT OF THE DISEASE
PH12016501357B1 (en) Pharmaceutical preparation containing pyridylaminoacetic acid compound
EA201592254A1 (en) DERIVATIVES OF Pyrazolopyrrolidin-4-IT and THEIR APPLICATION IN THE TREATMENT OF DISEASE
EA201291089A1 (en) METHOD FOR OBTAINING PHARMACEUTICAL PREPARATIONS INTENDED FOR ORAL ADMINISTRATION, CONTAINING ONE OR MORE ACTIVE INGREDIENTS AND CONTAINING COMPOSITIONS
EA201792072A2 (en) GLUTARIMIDES DERIVATIVES, THEIR APPLICATION, PHARMACEUTICAL COMPOSITION ON THEIR BASIS, METHODS OF THEIR PRODUCTION
MY179605A (en) Use of benzimidazole-proline derivatives
EA201691918A1 (en) PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE
WO2016057413A3 (en) Inhibitors of lysine gingipain
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
EA201690077A1 (en) THERAPEUTICALLY ACTIVE DERIVATIVES OF ESTRATRIEN-THIAZOLE
EA201792264A1 (en) METHODS OF TREATING INFLAMMATORY DISEASES
SG10201908690WA (en) Novel method of use and compositions
CY1117795T1 (en) PHARMACEUTICAL COMPOSITIONS EXCEPTION OF CITRUS SALT THAT INCLUDE
EA201792237A1 (en) PHARMACEUTICAL COMPOSITIONS
EA201791191A1 (en) WATER PHARMACEUTICAL COMPOSITIONS FOR LOCAL APPLICATION IN THE ORAL CAVITY CONTAINING FLURBIPROPHENE AND DEXPANTENOL
EA201891177A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIOUS AND INFLAMMATORY DISEASES OF LOCAL APPLICATION AND METHOD FOR ITS PREPARATION AND APPLICATION (OPTIONS)
EA201891176A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIOUS AND INFLAMMATORY DISEASES OF LOCAL APPLICATION AND METHOD FOR ITS PREPARATION AND APPLICATION
PL407711A1 (en) Derivatives of N-Guanyl derivatives of 9-amino-5,11-dimethyl-5H-indolo[2,3-b]quinoline, method for obtaining them and pharmaceuticals containing them